Literature DB >> 24790667

Small cell lung carcinoma associated with progressive systemic sclerosis.

Kaushik Saha1, Arnab Saha1, Prabodh Panchadhyayee1, Mrinmoy Mitra1, Tara Sankar Malik1, Pratik Barma1, Santanu Ghosh1.   

Abstract

ABSTRACT: The association between progressive systemic sclerosis (PSS) and malignancy is uncommon. The possibility of development of small cell carcinoma lung (SCLC), among all the reported lung malignancies in PSS patients is lowest. A fifty-five year old non-smoker female diagnosed as PSS for 1 year presented to our outpatient department with dry cough for 2 months, shortness of breath for the last 1 month and progressive facial and right upper limb oedema for the last 15 days. Chest X-ray showed homogenous opacity in the right upper and mid zones of lung and the obliteration of both costophrenic angles. High resolution computed tomography (CT) of the thorax revealed a right upper lobe lung mass with bilateral minimal pleural effusion and the presence of bilateral reticular opacities, with basal predominance, associated with septal thickening, suggestive of interstitial lung disease of non-specific interstitial pneumonia pattern. CT guided fine needle aspiration cytology (FNAC) from the right upper lobe mass was suggestive of small cell carcinoma. Patient was improved after 6 cycles of chemotherapy with carboplatin and etoposide.

Entities:  

Keywords:  interstitial fibrosis; progressive systemic sclerosis; small cell lung carcinoma

Year:  2013        PMID: 24790667      PMCID: PMC3968471     

Source DB:  PubMed          Journal:  Maedica (Buchar)        ISSN: 1841-9038


  8 in total

1.  Phase I/II study of altered schedule of cisplatin and etoposide administration and concurrent accelerated hyperfractionated thoracic radiotherapy for limited-stage small-cell lung cancer.

Authors:  Yoshihiko Segawa; Hiroshi Ueoka; Katsuyuki Kiura; Masahiro Tabata; Nagio Takigawa; Yoshio Hiraki; Yoichi Watanabe; Toshiro Yonei; Tomonori Moritaka; Junichiro Hiyama; Shunkichi Hiraki; Mitsune Tanimoto; Mine Harada
Journal:  Lung Cancer       Date:  2003-07       Impact factor: 5.705

2.  Diffuse interstitial pulmonary fibrosis and lung cancer.

Authors:  T Kawai; K Yakumaru; M Suzuki; K Kageyama
Journal:  Acta Pathol Jpn       Date:  1987-01

Review 3.  Scleroderma and scleroderma-like disorders.

Authors:  V K Rocco; E R Hurd
Journal:  Semin Arthritis Rheum       Date:  1986-08       Impact factor: 5.532

Review 4.  Small cell lung cancer associated with systemic sclerosis.

Authors:  Nobuhiro Kanaji; Jiro Fujita; Shuji Bandoh; Tetsuya Fukumoto; Masashi Ishikawa; Reiji Haba; Tomoya Ishii; Akihito Kubo; Toshihiko Ishida
Journal:  Intern Med       Date:  2005-04       Impact factor: 1.271

Review 5.  Lung cancer associated with several connective tissue diseases: with a review of literature.

Authors:  Y Yang; J Fujita; M Tokuda; S Bandoh; T Ishida
Journal:  Rheumatol Int       Date:  2001-11       Impact factor: 2.631

6.  Risk factors of treatment-related death in chemotherapy and thoracic radiotherapy for lung cancer.

Authors:  Y Ohe; S Yamamoto; K Suzuki; F Hojo; R Kakinuma; T Matsumoto; H Ohmatsu; Y Nishiwaki
Journal:  Eur J Cancer       Date:  2001-01       Impact factor: 9.162

7.  Interstitial lung disease in Japanese patients with lung cancer: a cohort and nested case-control study.

Authors:  Shoji Kudoh; Harubumi Kato; Yutaka Nishiwaki; Masahiro Fukuoka; Kouichiro Nakata; Yukito Ichinose; Masahiro Tsuboi; Soichiro Yokota; Kazuhiko Nakagawa; Moritaka Suga; Haiyi Jiang; Yohji Itoh; Alison Armour; Claire Watkins; Tim Higenbottam; Fredrik Nyberg
Journal:  Am J Respir Crit Care Med       Date:  2008-03-12       Impact factor: 21.405

8.  Lung cancer and interstitial lung diseases: a systematic review.

Authors:  Kostas Archontogeorgis; Paschalis Steiropoulos; Argyris Tzouvelekis; Evangelia Nena; Demosthenes Bouros
Journal:  Pulm Med       Date:  2012-07-29
  8 in total
  1 in total

1.  Small Cell Lung Cancer in a 20-year-old Non-Smoking Man with Systemic Sclerosis.

Authors:  Go Saito; Torahiko Jinta; Hiroshi Nakaoka; Atsushi Kitamura; Kenichi Yamaguchi; Naoki Nishimura
Journal:  Intern Med       Date:  2017-06-15       Impact factor: 1.271

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.